Study Sparks Renewed Interest in Targeting Androgen Receptor in Breast Cancer
Researchers discuss the potential of enobosarm, a selective androgen receptor modulator, for the treatment of ER-positive breast cancer that has progressed on at least 1 previous endocrine therapy.